RSC Pharmaceutics recently published its first articles, which can be read for free here. To celebrate publishing our first articles, we asked some of our authors to discuss their work in more detail.
In this post, we hear about the research from Chvíla et al. in their article titled “A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model”. Watch three of the authors, Eva Kudová, Stanislav Chvíla and František Štěpánek, talk about their work below or here!
 |
A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat modelStanislav Chvíla, Hana Kubová, Pavel Mareš, Eva Kudová and František Štěpánek RSC Pharm., 2024, Advance Article. DOI: 10.1039/D3PM00043E |
|
RSC Pharmaceutics provides researchers with a platform to publish research in pharmaceutics and advance this field. We are interested in any submission that shares new scientific findings across chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery. |
 |